Method and compounds for use in the treatment of steroid induced states of the central nervous system
US6455516B1 · kind B1 · utility
18Cited by
3References
4Claims
0Family size
Inventors
Key dates
| Filing date | Mar 11, 1999 |
| Grant date | Sep 24, 2002 |
| Priority date | — |
| Expiry date | Mar 11, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The use of epiallopregnanolone (3&bgr;-hydroxy-5&agr;-pregnan-20-one) for the treatment of steroid induced mood disorders and CNS disorders is disclosed. Further, the use of epiallopregnanolone for the manufacture of pharmaceuticals is disclosed, together with an list of symptoms suitable for treatment with epiallopregnanolone.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.